USD· Real-time
Loading widget...

AMGN earnings track record

Beat analyst EPS estimates in 5 of the last 5 reported quarters, averaging a +9.48% surprise. The most recent result moved the stock +4.57% in the following session.

QuarterReportedEPS est.EPS actualSurpriseNext session
Q2 20262026-08-04amc$5.73$6.29▲ +9.81%▲ +4.57%
Q1 2026$4.85$5.15▲ +6.14%
Q4 2025$4.83$5.29▲ +9.56%
Q3 2025$5.11$5.64▲ +10.28%
Q2 2025$5.39$6.02▲ +11.64%
Next session is the price move in the trading session the result actually landed in — the following day for a company reporting after the close (amc), the report day itself for one reporting before the open (bmo). A dash means the report date or the matching price is outside our history. Estimates and actuals: Finnhub; price data: our own daily series.

Recent AMGN events

  1. 2026-08-20AnalystBenzinga
    Piper Sandler Maintains Overweight on Amgen, Raises Price Target to $457
  2. 2026-08-18NewsBenzinga
    Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics; Termination Of Collaboration Agreement Effective November 10, 2026
  3. 2026-08-13EarningsYahoo
    Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions
  4. 2026-08-11NewsBenzinga
    $1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
  5. 2026-08-10AnalystBenzinga
    Guggenheim Maintains Neutral on Amgen, Raises Price Target to $388
  6. 2026-08-07NewsSeekingAlpha
    Amgen: The Market Is Underestimating Its Next Growth Phase
  7. 2026-08-05NewsYahoo
    Amgen Stock Climbs as Drug Growth Outruns Obesity Setback
  8. 2026-08-05EarningsYahoo
    Amgen Q2 2026 earnings beat, raises full-year outlook, drops AMG 513
  9. 2026-08-05GuidanceYahoo
    Amgen (AMGN) Lifted 2026 Guidance, Is The Valuation Still Too Rich?
  10. 2026-08-05EarningsYahoo
    Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ...
Company events classified by type from our own market-event feed. Headlines link to the original publisher.

Important Disclaimer — Not Investment Advice

Disclaimer: This article is provided by Money365.Market for general information and educational purposes only. It is not financial advice, a personal recommendation, or an inducement to buy, sell, or invest in any security or product. Capital is at risk and the value of investments can go down as well as up; past performance does not indicate future results. You should seek independent advice from an FCA-authorised adviser before making any financial decision.

Nothing here is an offer or a solicitation to buy or sell anything, and reading it creates no advisory or fiduciary relationship between you and Money365.Market. Any decision you take is your own.

  • You can lose money — including all of it. Individual companies can and do fail, and some of the assets discussed can fall to zero. Only commit money you can afford to lose, and never borrow to invest on the strength of anything you read here.
  • Forecasts are opinion, not fact. Any valuation model, scenario, fair-value range, estimate or other forward-looking statement is illustrative, rests on assumptions that may prove wrong, and is never a price target, a forecast of actual outcomes, or a promise of any return.
  • Published at a point in time. Figures were believed accurate on the publication or last-updated date shown above and are not maintained afterwards; we are under no obligation to update them. Market and company data comes from third-party sources and is provided without warranty of accuracy, completeness or timeliness.
  • We are not regulated. Money365.Market is not authorised or regulated by the UK Financial Conduct Authority, is not registered with the U.S. Securities and Exchange Commission or FINRA as an investment adviser or broker-dealer, and is not a tax adviser. We hold no licence to give personal financial advice and do not do so.
  • Interests and independence. Money365.Market is not affiliated with, endorsed by or sponsored by any company, fund, exchange or platform mentioned, and is not paid to feature them. The author may hold positions in securities or assets discussed. The site earns revenue from advertising, subscriptions and, where labelled, affiliate links; this does not influence what we publish.
  • Your jurisdiction matters. Tax treatment, contribution limits, product availability and investor protections differ by country and can change. Speak to a qualified tax professional for tax matters, and to a locally licensed adviser if you are outside the UK.

Full terms: Disclaimer · Terms of Service · Privacy Policy